Primary Aldosteronism Screening Rates Differ with Sex, Race, and Comorbidities

Genetics in Endocrinology: Impact of race and sex on genetic causes of aldosterone-producing adenomas

(2021) Kazutaka Nanba et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Clinical Score and Machine Learning-Based Model to Predict Diagnosis of Primary Aldosteronism in Arterial Hypertension

(2021) Fabrizio Buffolo et al.   HYPERTENSION

Time-Dependent Risk of Atrial Fibrillation in Patients With Primary Aldosteronism After Medical or Surgical Treatment Initiation

(2021) Kyoung Jin Kim et al.   HYPERTENSION

Prospective Screening for Primary Aldosteronism in Patients With Suspected Obstructive Sleep Apnea

(2021) Min Ru Chee et al.   HYPERTENSION

New-Onset Atrial Fibrillation in Patients With Primary Aldosteronism Receiving Different Treatment Strategies: Systematic Review and Pooled Analysis of Three Studies

(2021) Cheng-Hsuan Tsai et al.   Frontiers in Endocrinology

Screening Rates for Primary Aldosteronism Among Individuals With Hypertension Plus Hypokalemia: A Population-Based Retrospective Cohort Study

(2021) Gregory L. Hundemer et al.   HYPERTENSION

Screening Rates for Primary Aldosteronism in Resistant Hypertension

(2020) Gilad Jaffe et al.   HYPERTENSION

The Unrecognized Prevalence of Primary Aldosteronism

(2020) Jenifer M. Brown et al.   ANNALS OF INTERNAL MEDICINE

The Concordance between Imaging and Adrenal Venous Sampling Varies with Aldosterone-Driver Somatic Mutation

(2020) Taweesak Wannachalee et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Genetics, prevalence, screening and confirmation of primary aldosteronism

(2020) Paolo Mulatero et al.   JOURNAL OF HYPERTENSION

Evolution of the Primary Aldosteronism Syndrome: Updating the Approach

(2020) Anand Vaidya et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Testing for Primary Aldosteronism and Mineralocorticoid Receptor Antagonist Use Among U.S. Veterans

(2020) Jordana B. Cohen et al.   ANNALS OF INTERNAL MEDICINE

MANAGEMENT OF ENDOCRINE DISEASE: The role of surgical adrenalectomy in primary aldosteronism

(2020) Gregory L Hundemer et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019

(2020) Gregory A. Roth et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Prevalence of Apparent Treatment-Resistant Hypertension in the United States

(2019) Robert M. Carey et al.   HYPERTENSION

Renal damage in primary aldosteronism

(2019) Silvia Monticone et al.   JOURNAL OF HYPERTENSION

Clinical Outcomes of 1625 Patients With Primary Aldosteronism Subtyped With Adrenal Vein Sampling

(2019) Gian Paolo Rossi et al.   HYPERTENSION

The Effects of Eplerenone on the Circadian Blood Pressure Pattern and Left Ventricular Hypertrophy in Patients with Obstructive Sleep Apnea and Resistant Hypertension—A Randomized, Controlled Trial

(2019) Beata Krasińska et al.   Journal of Clinical Medicine

Primary Aldosteronism and Obstructive Sleep Apnea

(2019) Fabrizio Buffolo et al.   HYPERTENSION

Hypertension Canada’s 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children

(2018) Kara A. Nerenberg et al.   CANADIAN JOURNAL OF CARDIOLOGY

Renal Outcomes in Medically and Surgically Treated Primary Aldosteronism

(2018) Gregory L. Hundemer et al.   HYPERTENSION

Hypertension in Blacks

(2018) J. David Spence et al.   HYPERTENSION

Adrenalectomy Lowers Incident Atrial Fibrillation in Primary Aldosteronism Patients at Long TermNovelty and Significance

(2018) Gian Paolo Rossi et al.   HYPERTENSION

Apparent resistant hypertension and the risk of vascular events and mortality in patients with manifest vascular disease

(2018) Nicolette G.C. van der Sande et al.   JOURNAL OF HYPERTENSION

Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study

(2018) Gregory L Hundemer et al.   Lancet Diabetes & Endocrinology

Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis

(2018) Silvia Monticone et al.   Lancet Diabetes & Endocrinology

Incidence of Atrial Fibrillation and Mineralocorticoid Receptor Activity in Patients With Medically and Surgically Treated Primary Aldosteronism

(2018) Gregory L. Hundemer et al.   JAMA Cardiology

Keeping primary aldosteronism in mind: Deficiencies in screening at-risk hypertensives

(2018) Brian C. Ruhle et al.   SURGERY

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

(2017) Paul K. Whelton et al.   HYPERTENSION

Effect of spironolactone on patients with resistant hypertension and obstructive sleep apnea

(2016) Lirui Yang et al.   CLINICAL AND EXPERIMENTAL HYPERTENSION

Study Heterogeneity and Estimation of Prevalence of Primary Aldosteronism: A Systematic Review and Meta-Regression Analysis

(2016) Sabine C. Käyser et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline

(2016) John W. Funder et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Management of resistant hypertension: expert consensus statement from the French Society of Hypertension, an affiliate of the French Society of Cardiology

(2016) T Denolle et al.   JOURNAL OF HUMAN HYPERTENSION

Guidelines for primary aldosteronism

(2016) Paolo Mulatero et al.   JOURNAL OF HYPERTENSION

Cost-Effectiveness of Screening for Primary Aldosteronism and Subtype Diagnosis in the Resistant Hypertensive Patients

(2015) C. C. Lubitz et al.  

Cost-Effectiveness of Screening for Primary Aldosteronism and Subtype Diagnosis in the Resistant Hypertensive Patients

(2015) C. C. Lubitz et al.   Circulation-Cardiovascular Quality and Outcomes

Racial Differences in Hypertension: Implications for High Blood Pressure Management

(2014) Daniel T. Lackland   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

2013 ESH/ESC Guidelines for the management of arterial hypertension

(2013)   EUROPEAN HEART JOURNAL

Long-Term Cardio- and Cerebrovascular Events in Patients With Primary Aldosteronism

(2013) Paolo Mulatero et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis

(2013) Nancy J. Brown   Nature Reviews Nephrology

Demonstration of Blood Pressure-Independent Noninfarct Myocardial Fibrosis in Primary Aldosteronism

(2012) E. Marie Freel et al.   Circulation-Cardiovascular Imaging

Guidelines for the diagnosis and treatment of primary aldosteronism -The Japan Endocrine Society 2009-

(2011) Tetsuo Nishikawa et al.   ENDOCRINE JOURNAL

Relationship Between Overnight Rostral Fluid Shift and Obstructive Sleep Apnea in Drug-Resistant Hypertension

(2010) Oded Friedman et al.   HYPERTENSION

Increased levels of oxidative stress, subclinical inflammation, and myocardial fibrosis markers in primary aldosteronism patients

(2010) Carlos B Stehr et al.   JOURNAL OF HYPERTENSION

Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report

(2009) K Gaddam et al.   JOURNAL OF HUMAN HYPERTENSION